Clinical trial
Clinical Trial to Evaluate the Efficacy of Metadoxine as a Therapy for Patients With Non-alcoholic Steatohepatitis
NCT02541045 is registered in ClinicalTrials.gov with Hospital General de Mexico as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Trial to Evaluate the Efficacy of Metadoxine as a Therapy for Patients With Non-alcoholic Steatohepatitis
- Lead sponsor
- Hospital General de Mexico
- Phase
- Phase 3
- Overall status
- Withdrawn
- Start date
- August 31, 2015
- Completion date
- March 31, 2024
- Enrollment
- 0 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
non-alcoholic steatohepatitis